Article info
PDFColorectal
Original research
Association of trough vedolizumab levels with clinical, biological and endoscopic outcomes during maintenance therapy in inflammatory bowel disease
- Correspondence to Dr Nikolas Plevris, The Edinburgh IBD Unit, Western General Hospital, Edinburgh, UK; n.plevris12{at}gmail.com
Citation
Association of trough vedolizumab levels with clinical, biological and endoscopic outcomes during maintenance therapy in inflammatory bowel disease
Publication history
- Received February 7, 2019
- Revised May 16, 2019
- Accepted June 13, 2019
- First published July 3, 2019.
Online issue publication
February 10, 2020
Article Versions
- Previous version (10 February 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.